Mirror Biologics, Inc.

This study compares a new immunotherapy called AlloStim against standard drug treatments for adults with advanced liver cancer that cannot be treated with surgery or local therapies. The trial aims to see if AlloStim helps patients live longer and have a better quality of life th…

This study aimed to test whether a two-part experimental immunotherapy could help control advanced colorectal cancer that had stopped responding to all standard treatments. It was designed for patients whose cancer had spread and who had already tried and failed at least three pr…